Study: Recovered COVID-19 Patients Possess Robust Immunity To Virus

The Federalist ^ | 7/26/2021 | Shawn Fleetwood

[Signalman]

A newly released study conducted by Emory University suggests recovered COVID-19 patients possess long-term immunity to the respiratory virus months after infection.

Published in Cell Reports Medicine, the comprehensive study analyzed 254 individuals with mostly mild to moderate symptoms of SARS-CoV-2 infection over an eight-month period and found that patients possessed “durable broad-based immune responses” to the virus after recovering from an infection.

“The study serves as a framework to define and predict long-lived immunity to SARS-CoV-2 after natural infection,” said Emory Vaccine Center director Rafi Ahmed. “We also saw indications in this phase that natural immunity could continue to persist.” Ahmed served as a lead author on the study.

The study goes on to note that in response to an active infection in the body, the human immune system produces a multitude of neutralizing antibodies, while also activating certain T and B cells to establish immune memory. Ahmed denotes that these developments make a strong case for some form of lasting immunity to the virus.

“We saw that antibody responses, especially IgG antibodies, were not only durable in the vast majority of patients but decayed at a slower rate than previously estimated, which suggests that patients are generating longer-lived plasma cells that can neutralize the SARS-CoV-2 spike protein,” he said.

Moreover, the analysis also demonstrates that not only are recovered patients likely to possess lasting immunity to existing SARS-COV-2 variants, but that “SARS-CoV-2 infection also boosts antibody titers to SARS-CoV-1 and common betacoronaviruses.”

“While pre-existing exposure and antibodies against HKU1 and OC43 betacoronaviruses are common in adults, pre-existing SARS-CoV-1 exposure is rare and antibody levels to SARS-CoV-1 spike protein were very low (essentially negative) in the pre-pandemic healthy controls,” the study says. “However, SARS-CoV-1 spike-reactive antibodies increased significantly after SARS-CoV-2 infection.”

The report later goes on to conclude that taken together, the results of the study “suggest that broad and effective immunity may persist long-term in recovered COVID-19 patients.”

The study’s participants are expected to be evaluated by the Emory research team over the next few years as part of continued research on the matter.

[frogjerk]

I tested positive in Nov 2020, was in close contact with two others that also tested postive, they had symptoms and as did I. I had a head cold for about 5 days, took advil once and did some yard work and worked thru it while I passed the 10 day quarantine. I had a funny feeling in my nasal passage like I had chlorine up my nose from pool water but never lost my sense of taste or smell. I've had much worse illnesses from norovirus and allergies.

I would never consider myself a "survivor" or some sort of martyr like the libs you mention.

[gitmo]

My family of 4 got COVID in April.
My wife and my younger son were hospitalized with pneumonia.
My older son and I had no symptoms at all.

It’s interesting that my wife had been on HCQ for ten years. And our doctor put us all on Ivermectin.